Close Menu


The Department of Cancer Immunology and AIDS at Dana-Farber will use the synthetic biology platform as part of research to develop transient immunity against life-threatening viral infections.

Proteomika plans to launch kits in the second quarter of this year containing the HuCAL antibodies that can help monitor certain biopharmaceutical therapies.

Movers & Shakers: May 13, 2011


Arthur Moseley, David Lemus, Rainer Metternich, William Curry

Movers & Shakers: Feb 25, 2011


Ruedi Aebersold, Anne Ferguson-Smith, Jeannie Lee, Diane Mathis, Dave Anderson, William Thomsen, Jens Holstein, Dave Lemus

Per the arrangement, Morphosys will receive an upfront payment of an undisclosed amount this year, with the possibility of annual license fees over the patent lifetime of the Slonomics platform.

Sloning will install its Slonomics platform at Pfizer's subsidiary Rinat Neuroscience and provide training and use of the platform.

According to MorphoSys, the deal will allow it to improve the success rate for new antibody drug candidate development to the point where 50 percent of new projects will reach clinical development.

The technique, which is being developed on AB Sciex's QTRAP 5500 and TripleTOF 5600 machines, could help drugmakers better track the metabolism of their biopharmaceutical agents in vivo, improving studies of their efficacy and safety, said a researcher.

The company will use part of the €1 million award to investigate biomarkers that will aid in determining which patients are the best candidates for treatment with its MOR202 antibody program, a company official said.

As part of the effort, MorphoSys will explore relevant biomarkers for the anti-CD38 approach in collaboration with the university hospital of Munich Technical University.


A new analysis suggests warming, not the arrival of humans, led to the extinction of the woolly rhinoceros thousands of years ago, the Economist reports.

Chinese health officials uncovered SARS-CoV-2 viral RNA on imported frozen food, but the New York Times reports catching COVID-19 that way would be unlikely.

The UK has ordered 60 million coronavirus vaccine doses from Novavax and 30 million doses from Janssen, according to the Guardian.

In Science this week: machine learning model predicts whether ion channel mutations will cause disease, and more.